Laurion Capital Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-686,533
| Closed | -$5.55M | – | 346 |
|
|
2023
Q1 | $5.55M | Sell |
686,533
-515,268
| -43% | -$4.17M | 0.04% | 67 |
|
|
2022
Q4 | $18.9M | Sell |
1,201,801
-102,823
| -8% | -$1.62M | 0.09% | 33 |
|
|
2022
Q3 | $20.5M | Sell |
1,304,624
-135,451
| -9% | -$2.13M | 0.12% | 39 |
|
|
2022
Q2 | $20.1M | Hold |
1,440,075
| – | – | 0.31% | 22 |
|
|
2022
Q1 | $24.8M | Buy |
1,440,075
+325,000
| +29% | +$5.6M | 0.3% | 27 |
|
|
2021
Q4 | $16.2M | Buy |
1,115,075
+622,575
| +126% | +$9.05M | 0.16% | 48 |
|
|
2021
Q3 | $8.87M | Sell |
492,500
-41,162
| -8% | -$741K | 0.04% | 111 |
|
|
2021
Q2 | $9.37M | Buy |
533,662
+493,962
| +1,244% | +$8.67M | 0.05% | 76 |
|
|
2021
Q1 | $1M | Buy |
+39,700
| New | +$1M | 0.01% | 293 |
|